Exelixis (EXEL) Stock Forecast & Price Target

EXEL$70.30-0.28 -0.40%
BiotechnologyLarge CapHigh Quality
Compare
Market cap$17.67BEnterprise value$18.14BRevenue (TTM)$2.50BMarket positionTop 25%

Score

64
Neutral
Value
43
Quality
95
Growth
54

Exelixis, Inc. price target

EXEL
Low$49.00
Average$53.00
High$60.00
Upside vs current price-24.6%

The average target of $53.00 is -24.6% versus the current EXEL price of $70.30.

Exelixis, Inc. analyst ratings

RatingAnalysts
Strong buy1
Buy5
Hold10
Sell0
Strong sell1
ConsensusHold

17 analysts cover EXEL.

Exelixis, Inc. EPS and revenue estimates

Published annual figures for EXEL on this page are 2026 EPS $2.98, 2027 EPS $3.71. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$2.98$2.32B
2027$3.71$2.56B

Is Exelixis, Inc. a buy or sell?

Of the 17 analysts covering Exelixis, Inc., 6 rate it a buy (1 strong buy and 5 buy), 10 rate it a hold, and 1 rates it a sell (0 sell and 1 strong sell).

The EXEL consensus label is Hold, beside 6 buy-side ratings and 1 sell-side ratings.

The average target of $53.00 implies -24.6% versus the current price of $70.30.

The EXEL rating block is 17 published views with a Hold label. It does not tell you whether to buy or sell.

Reading the Exelixis, Inc. forecast

the Exelixis, Inc. is priced by the street between $49.00 and $60.00, average $53.00.

The gap from the $70.30 price to the EXEL average is -24.6%.

the Exelixis, Inc. does not have a single rating camp: 6 of 17 analysts are on the buy side, 10 are at hold, and 1 is on the sell side, and the published consensus is Hold.

The EXEL average target is little changed, $52.00 over the last month and $52.33 over the last quarter.

the Exelixis, Inc. is followed by 17 analysts, so the range matters more than any one target.

Exelixis, Inc. forecast questions

What is the EXEL price target?

The published range for EXEL is $49.00 to $60.00, with an average of $53.00. That average is -24.6% versus the current price of $70.30.

Is Exelixis, Inc. a buy or sell?

Of the 17 analysts covering Exelixis, Inc., 6 rate it a buy, 10 rate it a hold, and 1 rates it a sell. The consensus is Hold, leaving EXEL at 6 buy ratings, 10 holds, and 1 sells.

What is the EPS estimate for Exelixis, Inc.?

Analyst EPS estimates for Exelixis, Inc.: 2026 $2.98, 2027 $3.71.

What is the revenue estimate for Exelixis, Inc.?

Analyst revenue estimates for Exelixis, Inc.: 2026 $2.32B, 2027 $2.56B.

How many analysts cover EXEL?

17 analysts cover EXEL. Their consensus on EXEL is Hold, across those 17.

EXEL price $70.30 -0.28 -0.40%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener